CYDY · CytoDyn Inc. · Share Buybacks
$0.25
+0.00 (+0.04%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Oct 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company had an accumulated deficit of approximately $950.4 million as of August 31, 2026. These factors, among several others, raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Oct 14, 2026
Market Cap
$367.38M
Shares
1.47B
Volume · Oct 20
7.35M
Avg daily vol (3M)
1.68M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
No Buyback Data
This company's XBRL filings report no share-repurchase activity yet.